Study Title: OPTIMICE-PCR: De-Escalation of Therapy in Early-Stage TNBC Patients who Achieve PCR After Neoadjuvant Chemotherapy with Checkpoint Inhibitor Therapy
For more information about the trial above please contact the study team:Trial opened at the following institutions: Lexington Medical Center, Tidelands Health